DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Buspirone Hydrochloride is a drug marketed by Accord Hlthcare, Amneal Pharms Co, Aurobindo Pharma Ltd, Egis, Epic Pharma Llc, Fosun Pharma, Heritage Pharma, Impax Labs Inc, Inventia Hlthcare, Ivax Sub Teva Pharms, Mylan, Nesher Pharms, Oxford Pharms, Rubicon, Strides Pharma, Teva, Unichem, Yiling, and Zydus Pharms. and is included in twenty-one NDAs.
The generic ingredient in BUSPIRONE HYDROCHLORIDE is buspirone hydrochloride. There are nineteen drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the buspirone hydrochloride profile page.
A generic version of BUSPIRONE HYDROCHLORIDE was approved as buspirone hydrochloride by IMPAX LABS INC on March 28th, 2001.
Recent Clinical Trials for BUSPIRONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Spaulding Rehabilitation Hospital||Phase 2|
|Online PsychoTherapy Clinic||N/A|